The relevance of these findings needs to be further investigated in a well-powered patient cohort, as it may be indicative of a crosstalk between platelet-coated tumor cells and lymphocytes via the GITR/GITRL axis. The gene discussed is TNFRSF18; the disease is neoplasm.